Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 329-334

  Kuss, Iris ^a   Saito, Takao ^a   Johnson, Jonas T ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTE SUBSETS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0032972946     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Young, M. R. I., Wright, M. A., Lozano, Y., Mathews, J. P., Benefield, J., and Prechel, M. M. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int. J. Cancer, 67: 333-338, 1996.
2. Whiteside, T. L. Tumor-infiltrating lymphocytes in head and neck cancer. In: A. E. Chang and S. Shu (eds.), Immunotherapy of Cancer With Sensitized T Lymphocytes, pp. 133-154. Austin, TX: R. G. Landes Co., 1994.
3. Reichert, T. E., Rabinowich, H., Johnson, J. T., and Whiteside, T. L. Human immune cells in the tumor microenvironment: mechanism responsible for signaling and functional defects. J. Immunother., 21: 295-306, 1998.
4. Ioannides, C. G., and Whiteside, T. L. T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin. Immunol. Immunopathol., 66: 91-106, 1993.
5. Whiteside, T. L., and Rabinowich, H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol. Immunother., 46: 175-184, 1998.
6. Lai, P., Rabinowich, H., Crowley-Nowick, P. A., Bell, M. C., Mantovani, G., and Whiteside, T. L. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res., 2: 161-173, 1996.
7. Xiaoli, L., Jun, L., Jeong-Kyu, P., Hamilton, T. A., Rayman, P., Klein, E., Edinger, M., Tubbs, R., Bukowski, R., and Finke, J. T cells from renal cell carcinoma patients exhibit an abnormal pattern of κB-specific DNA-binding activity: a preliminary report. Cancer Res., 54: 5424-5429, 1994.
8. Healy, C. G., Simons, J. W., Carducci, M. A., DeWeese, T. L., Bartkowski, M., Tong, K. P., and Bolton, W. E. Impaired expression and function of signal-transducing ζ chains in peripheral T cells and natural killer cells in patients with prostate cancer. Cytometry. 32: 109-119, 1998.
9. Matsuda, M., Petersson, M., Lenke, R., Taupin, J-L., Magnusson, I., Mellstedt, H., Anderson, P., and Kiessling, R. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer., 61: 765-772, 1995.
10. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J-L., Vivier, E., Anderson, P., and Kiessling, R. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610-5612, 1993.
11. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613-5616, 1993.
12. Kono, K., Ressing, M. E., Brandt, R. M. P., Melief, C. J. M., Potkul, R. K., Andersson, B., Petersson, M., Kast, W. M., and Kiessling, R. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin. Cancer Res., 2: 1825-1828, 1996.
13. Rabinowich, H., Banks, M., Reichert, T. E., Logan, T. F., Kirkwood, J. M., and Whiteside, T. L. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res., 2: 1263-1272, 1996.
14. Salvadori, S., and Zier, K. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2. J. Immunol., 156: 2927-2932, 1996.
15. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., and Ochoa, A. C. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (Washington DC), 258: 1795-1797, 1992.
16. Zea, A. H., Brendan, C. D., Longo, D. L., Alvord, W. G., Strobl, S. L., Mizoguchi, H., Creekmore, S. P., O'Shea, J. J., Powers, G. C., Urba, W. J., and Ochoa, A. C. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res., 1: 1327-1335, 1995.
17. Harras, A. (ed.). Cancer Rates and Risks, Ed. 4. Bethesda, MD: Cancer Statistics Branch, National Cancer Institute, United States Department of Health and Human Services, 1996.
18. Travis, J. Do tumor-altered T cells depress immune responses? Science (Washington DC), 258: 1732-1733, 1992.
19. Rabinowich, H., Suminami, Y., Reichert, T. E., Crowley-Nowick, P., Bell, M., Edwards, R., and Whiteside, T. L. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int. J. Cancer, 68: 276-284, 1996.
20. Buggins, A. G. S., Hirst, W. J. R., Pagliuca, A., and Mufti, G. J. Variable expression of CD3-ζ and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies. Br. J. Haematol., 100: 784-792, 1998.
21. Cardi, G., Heaney, J. A., Schned, A. R., Phillips, D. M., Branda, M. T., and Ernstoff, M. S. T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res., 57: 3517-3519, 1997.
22. fyn, ZAP-70, and CD3ζ despite suppressed cytolytic activity. J. Exp. Med., 182: 1029-1036, 1995.
23. Aoe, T., Okamoto, Y., and Saito, T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med., 181: 1881-1886, 1995.
24. Franco, J. L., Ghosh, P., Wiltrout, R. H., Carter, C. R. D., Zea, A. H., Momozaki, N., Ochoa, A. C., Longo, D. L., Sayers, T. J., and Komschlies, K. L. Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice. Cancer Res., 55: 3840-3846, 1995.
25. Rabinowich, H., Reichert, T. E., Kashii, Y., Bell, M. C., and Whiteside, T. L. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: implications for altered expression of TcR in tumor-associated lymphocytes. J. Clin. Invest., 101: 2579-2588, 1998.
26. Reichert, T. E., Day, R., Wagner, E., and Whiteside, T. L. Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res., 58: 5344-5347, 1998.
27. Kono, K., Salazar-Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., and Kiessling, R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell and natural killer cell-mediated cytotoxicity. Eur. J. Immunol., 26: 1308-1313, 1996.
28. Kiessling, R., Kono, K., Petersson, M., and Wasserman, K. Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Springer Semin. Immunopathol., 18: 227-242, 1996.
29. Farace, F., Angevin, E., Vanderplancke, J., Escudier, B., and Triebel, F. The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer, 59: 752-755, 1994.